Vertex Pharmaceuticals Incorporated

NasdaqGS:VRTX

Market Cap

USD 120.60 B

Share Price

USD 469.65

Avg Daily Volume

1,649,161

Change (1 day)

-0.56%

Change (1 year)

-4.59%

Change (YTD)

16.62%

Vertex Pharmaceuticals Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -2.51%

Vertex Pharmaceuticals Incorporated EBIT Margin is -2.51% for the Trailing 12 Months (TTM) ending March 31, 2025, a -105.31% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Vertex Pharmaceuticals Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 47.25%, a -3.39% change year over year.
  • Vertex Pharmaceuticals Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 48.90%, a 27.87% change year over year.
  • Vertex Pharmaceuticals Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 38.24%, a -26.55% change year over year.
  • Vertex Pharmaceuticals Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 52.07%, a 40.18% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin